Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced new data that demonstrate patients with intermediate-risk pulmonary embolism (PE) treated with Penumbra's computer ...

Its products primarily comprise FlowTriever and ClotTriever systems, which are used to treat venous thromboembolism (VTE), deep vein thrombosis (DVT), and pulmonary embolism (PE). The company also ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

The Element system is compatible with the Lightning Flash 2.0 mechanical thrombectomy system for the removal of venous thrombus and the treatment of pulmonary embolism. The Element device effectively ...

A mom who takes nothing for granted is sharing her story after almost dying from a pulmonary embolism during childbirth.

Smart Investor: Why the Bond Selloff May Be Good News, Will the Fed Still Cut Rates, and What’s Next for the AI Trade. We wrap up our coverage of the markets and the week. We sell different ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Mechanical thrombectomy is effective and safe for treating pulmonary embolism (PE).

Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the fourth ...